 |
 Video: What is a Stock Split?
|
|
|
| Biospecifics Technologies is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum (CCH). Co. maintains intellectual property with respect to injectable CCH that treats, among other indications, Dupuytren's contracture (DC), Peyronie's disease (PD), frozen shoulder syndrome, and uterine fibroids. Injectable CCH is approved and marketed under the trademark XIAFLEX® for the treatment of both DC and PD. Co. is evaluating CCH as a treatment for uterine fibroids. Under its license agreement with Endo International plc's (Endo), Endo has the right to develop CCH for frozen shoulder and plantar fibromatosis, and other licensed indications. According to our BSTC split history records, Biospecifics Tech has had 1 split. | |
|
Biospecifics Tech (BSTC) has 1 split in our BSTC split history database. The split for BSTC took place on April 21, 1992. This was a 2 for 1
split, meaning for each share of BSTC owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.
When a company such as Biospecifics Tech splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the BSTC split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biospecifics Tech shares, starting with a $10,000 purchase of BSTC, presented on a split-history-adjusted basis factoring in the complete BSTC split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/21/2015 |
|
| End date: |
12/02/2020 |
|
| Start price/share: |
$39.65 |
|
| End price/share: |
$88.53 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
123.28% |
|
| Average Annual Total Return: |
14.67% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$22,329.59 |
|
| Years: |
5.87 |
|
|
|
| Date |
Ratio |
| 04/21/1992 | 2 for 1
|
|
|
Free BSTC Email Alerts:
